Press Release

REGiMMUNE Completes $9.2 Million Series D Financing

REGiMMUNE Completes $9.2 Million Series D Financing Tokyo, Japan – February 14, 2014 – REGiMMUNE Corporation announced the closing of a Series D financing earlier this month. The company raised $9.2 million US in this new round, which was led by Japan Asia Investment Co …

RGI-2001 was granted Orphan Drug Designation from FDA

RGI-2001 has been granted Orphan Drug Designation for RGI-2001 from FDA Tokyo, Japan-(OCT. 28, 2012) – REGiMMUNE Corporation announced today that RGI-2001, the company’s liposomal formulation of alpha-GalCer, has been granted Orphan Drug Designation by the U.S. Food � …